[Federal Register Volume 64, Number 108 (Monday, June 7, 1999)]
[Notices]
[Pages 30339-30340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-14297]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


General and Plastic Surgery Devices Panel of the Medical Devices 
Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting may be closed to the public.
    Name of Committee: General and Plastic Surgery Devices Panel of the 
Medical Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 16, 1999, 10 a.m. 
to 5 p.m.
    Location: Hilton Hotel, Salons C, D, and E, 620 Perry Pkwy., 
Gaithersburg, MD.
    Contact Person: David Krause, Center for Devices and Radiological 
Health (HFZ-410), Food and Drug Administration, 9200 Corporate Blvd., 
Rockville, MD 20850, 301-594-3090, ext. 141, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12519. Please call the Information Line or access the 
Internet (http://www.fda.gov/cdrh/upadvmtg) for up-to-date information 
on this meeting.
    Agenda: The committee will discuss, make recommendations, and vote 
on premarket approval application for computer-guided surgical 
instruments for use in endoscopic surgery.
    Procedure: On June 16, 1999, from 10 a.m. to 1:30 p.m., and from 2 
p.m. to 5 p.m., the meeting is open to the public. Interested persons 
may present data, information, or views, orally or in writing, on 
issues pending before the committee. Written submissions may be made to 
the contact person by June 11,

[[Page 30340]]

1999. Oral presentations from the public will be scheduled between 
approximately 10:15 a.m. and 10:45 a.m. and between approximately 3 
p.m. and 3:30 p.m. Time allotted for each presentation may be limited. 
Those desiring to make formal oral presentations should notify the 
contact person before June 9, 1999, and submit a brief statement of the 
general nature of the evidence or arguments they wish to present, the 
names and addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation.
    Closed Committee Deliberations: On June 16, 1999, from 1:30 p.m. to 
2 p.m., the meeting will be closed to permit discussion and review of 
trade secret and/or confidential commercial information (5 U.S.C. 
552b(c)(4)). This portion of the meeting will be closed to permit 
discussion of this information.
    FDA regrets that it was unable to publish this notice 15 days prior 
to the June 16, 1999, General and Plastic Surgery Devices Panel of the 
Medical Devices Advisory Committee meeting. Because the agency believes 
there is some urgency to bring this issue to public discussion and 
qualified members of the General and Plastic Surgery Devices Panel of 
the Medical Devices Advisory Committee were available at this time, the 
Commissioner concluded that it was in the public interest to hold this 
meeting even if there was not sufficient time for the customary 15-day 
public notice.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 2, 1999.
Jane E. Henney,
Commissioner of Food and Drugs.
[FR Doc. 99-14297 Filed 6-3-99; 11:59 am]
BILLING CODE 4160-01-F